Shree Ganesh Remedies Limited

BOM:SGRLHealthcare

——At close · Market cap —

SGRL · Income statement · TradingHolo

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Revenue	0.5	0.7	0.9	1.3	1.1	1.1	+0.6%
Cost of revenue	0.2	0.4	0.5	0.6	0.4	0.6	+77.7%
Gross profit	0.3	0.3	0.4	0.7	0.7	0.5	−37.4%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Selling, general & administrative	0.0	0.0	0.1	0.1	0.1	0.2	+107.4%
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—
Operating expenses	0.1	0.1	0.1	0.1	0.1	0.2	+107.4%
Operating income	0.2	0.2	0.2	0.6	0.3	0.2	−20.1%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	+69.1%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	(0.1)	0.0	0.0	(0.2)	0.0	(0.0)	−198.2%
Pre-tax income	0.1	0.2	0.2	0.4	0.3	0.2	−23.2%
Income tax	0.0	0.0	0.1	0.1	0.1	0.1	−23.7%
Net income	0.1	0.1	0.2	0.3	0.2	0.2	−23.0%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	8.07	11.08	13.86	22.34	17.96	13.83	−23.0%
EPS, diluted (per share)	8.07	11.08	13.86	22.34	17.96	13.83	−23.0%
EBITDA	0.2	0.2	0.3	0.4	0.4	0.4	−3.0%
Depreciation & amortization	0.0	0.0	0.0	0.1	0.1	0.1	+9.5%
Weighted average shares (shares)	12,093,487	12,092,467	12,277,479	12,583,000	12,844,000	12,842,000	−0.0%
Weighted average diluted shares (shares)	12,093,487	12,092,467	12,277,479	12,583,000	12,844,000	12,842,000	−0.0%
Gross margin	55.1%	48.0%	47.7%	53.6%	67.0%	41.7%	−25.3 pts
Operating margin	39.9%	21.5%	22.8%	45.5%	28.3%	22.5%	−5.8 pts
Net margin	19.9%	18.8%	18.9%	22.3%	21.2%	16.3%	−5.0 pts

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.